TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer

BMC Research Notes

Table 1 Clinical and histological data of malignant and normal adjacent breast tissues.

Tissue type	Age	Size (mm)	Tumor stage	grade	Histological type	Menoposal status	ER	PR	Her2/neu	P53
Adjacent	50
Adjacent	38						-	-	-	+
Malignant	38	18	IIA	III	IDC	pre	+	+	-
Malignant	38	20		III	IDC	pre	3+	3+	2+
Malignant	58	35	IIIA	II	IDC	post	-	-	-	+
Malignant	80	10		I	IDC	post	+	+	-
Malignant	54	30	IIB	II	IDC	post
Adjacent							+	+	3+	+
Malignant	40	25	IIB	II	IDC	pre	+	+	-	+
Malignant	35	20		III	IDC	post
Adjacent
Malignant							+	+	-	+
Malignant	52	21	IIA	II	IDC	post	+	+	-	+
Malignant			III		IDC		+	-	-	+
Malignant	82	50	IIB	III	IDC	post
Adjacent	43						+	+	-	-
Malignant	50	50	IIA	II	IDC	pre	3+	3+	-
Malignant	44	20	IIIA	III	IDC	pre	+	+	-
Malignant	51	20	IIA	II	IDC	post
Malignant							+	+	-	-
Malignant	37	60	IIIB	II	IDC	post
Malignant	45				IDC	pre	+	+	-
Malignant	40	15	IB	II	IDC	pre	-	-	-	+
Malignant	42	20	IV	III	IDC	pre	+	+	-	+
Malignant	52	21	IIA	II	IDC	post	+	+	-	-
Malignant	50	8	IIA	II	IDC	post	+	+	-
Malignant	54	30	IIA	II	IDC	post	-	-	-	-
Malignant	45		IV		IDC	pre
Adjacent	45
Adjacent	40
Adjacent	52
Adjacent	42						-	-	-	-
Malignant	53				IDC+DCIS	pre	+	+	3+	-
Malignant	34	10	IIB	II	IDC+DCIS	pre	-	-	-	+
Malignant	56	38	IIB	II	IDC	post	+	+	-
Malignant	71	20	IV	II	IDC	post	-	-	-	-
Malignant	34	30	IIA	II	IDC	pre	+	+	3+
Malignant	37			II	IDC	pre	-	-	-
Malignant	48	30	IIB		ILC	pre	+	+	-	+
Malignant	43	18	I			pre	-	+	-
Malignant	45	20	II	II	ILC	pre	-	-	3+	+
Malignant	39	100	IIIA	II	IDC	pre
Malignant	34	60		III	IDC	pre
Malignant
Normal	25
Normal	38
Normal	32
Normal							+	+	-	-
Malignant	50	15	IB	I	IDC	pre	-	-	3+	+
Malignant	32	10	IV	II	IDC	pre	+	-	-
Malignant	60	30	IV	II	IDC	post	+	+	-	-
Malignant	41	50	IV	I	IDC	pre

Stage grouping are based on American Joint Committee on Cancer (AJCC). Estrogen receptor(ER), progesterone receptor (PR), Her2/neu and P53 status are based on IHC results. Invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC)

ISSN: 1756-0500